Humana Inc.
Price Action
Technical Summary
CONSOLIDATINGHumana Inc. is in a consolidation phase, trading with mixed signals as moving averages converge. Relative strength is leading (RS Rating: 93), indicating clear outperformance against the broad market. Earnings contraction of 5% provides fundamental context to the price action. However, price is extended 28% above the 50-day line, increasing the risk of a mean reversion.
Trend Template (Minervini)
Price vs Moving Averages
| Period | Value | Spread | Signal |
|---|---|---|---|
| 20 SMA | $340.72 | +5.85% | ABOVE |
| 50 SMA | $281.84 | +27.96% | ABOVE |
| 100 SMA | $231.61 | +55.71% | ABOVE |
| 150 SMA | $240.12 | +50.19% | ABOVE |
| 200 SMA | $248.94 | +44.87% | ABOVE |
Price Performance
Technical Indicators
Risk Profile
Volume Analysis
Earnings Momentum
Growth Trends
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity
Key Metrics
Frequently Asked Questions
Is HUM in an uptrend right now?
HUM has a trend score of 2/4 based on Minervini's Stage Analysis. Currently showing partial alignment - 2 of 4 trend criteria are met.
Is HUM overbought or oversold?
HUM's RSI (14) is 70. The stock is in neutral territory, neither overbought nor oversold.
Is HUM outperforming the market?
HUM has a Relative Strength (RS) Rating of 93 out of 99. Yes, HUM is a market leader, outperforming 93% of all stocks over the past 12 months.
Where is HUM in its 52-week range?
HUM is trading at $360.65, which is 95% of its 52-week high ($380.86) and 91% above its 52-week low ($163.11).
How volatile is HUM?
HUM has a Beta of 0.57 and 52-week volatility of 49%. It's less volatile than the S&P 500 - generally more stable.